Description
KPV 10 mg is a tripeptide (Lys-Pro-Val) corresponding to the C-terminal sequence of α-MSH. Studied in anti-inflammatory and gut-mucosal research.
Research Profile
- α-MSH C-terminal tripeptide
- Studied in anti-inflammatory, mucosal, and gut-health research
- Active area of academic research
- QC verified by HPLC and mass spectrometry
Specifications
- Compound: KPV
- Dosage: 10 mg per vial
- Purity: ≥ 98% (HPLC)
- Form: Lyophilized powder
- Storage: 2–8 °C (lyophilized); –20 °C (reconstituted)
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.





Reviews
There are no reviews yet.